A phase III study comparing the clinical utility of four regimens of 5‐Fluorouracil. A preliminary report

A clinical trial involving 462 colon, rectum, and breast cancer patients randomized among four different dosage regimens of 5‐FU (an intravenous loading course, a weekly intravenous schedule, a nontoxic schedule, and an oral schedule) has shown a significantly better response among colon‐rectum cancer patients for the intravenous loading course. In addition, duration of response and time to progression are also significantly better. Overall survival is approaching significance for the colon rectum group (p value .082). In contrast, breast cancer patients show little difference between treatments. Toxicity is somewhat higher for the loading course.

[1]  J. Klotz.  Truncated Geometric Response-Duration of Response Models for Clinical Trials , 1976 .

[2]  R. Hahn,et al.  A double‐blind comparison of intensive course 5‐fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma , 1975, Cancer.

[3]  W. Reeves,et al.  Treatment of cancer with weekly intravenous 5‐fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG) , 1971, Cancer.

[4]  W. Wolberg,et al.  The relation of thymidine labeling index in human tumors in vitro to the effectiveness of 5-fluorouracil chemotherapy. , 1971, Cancer research.

[5]  N. Breslow.  A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .

[6]  G. Ramírez,et al.  Comparative study of monthly courses versus weekly doses of 5-fluorouracil (NSC-19893). , 1969, Cancer chemotherapy reports.

[7]  J. Luce,et al.  Treatment of cancer with weekly intravenous 5‐fluorouracil , 1968, Cancer.

[8]  J. Klotz.  The Wilcoxon, Ties, and the Computer , 1966 .

[9]  F. Ansfield.  A LESS TOXIC FLUOROURACIL DOSAGE SCHEDULE. , 1964, JAMA.

[10]  J. M. Schroeder,et al.  Five years clinical experience with 5-fluorouracil. , 1962, JAMA.

[11]  R. Ottoman,et al.  Use of 5‐Fluorouracil in Disseminated Solid Neoplasms , 1962, Annals of surgery.

[12]  K. Olson,et al.  Evaluation of 5-fluorouracil in the treatment of cancer. , 1960, Journal of the National Cancer Institute.

[13]  Vaitkevicius Vk,et al.  5-Fluorouracil in clinical cancer experience with 155 patients. , 1960 .

[14]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[15]  C. Heidelberger,et al.  Clinical studies with 5-fluorouracil. , 1958, Cancer research.

[16]  W. Kruskal,et al.  Use of Ranks in One-Criterion Variance Analysis , 1952 .

[17]  L. Irwin,et al.  5‐fluorouracil given once weekly: Comparison of intravenous and oral administration , 1971, Cancer.

[18]  T. Hall,et al.  Treatment of metastatic colorectal carcinoma with 5‐fluorouracil by mouth , 1971, Cancer.